Last reviewed · How we verify
Seasonal influenza virus vaccine
Seasonal influenza virus vaccine is a Influenza vaccine Small molecule drug developed by AstraZeneca. It is currently in Phase 3 development for Prevention of seasonal influenza disease.
This vaccine induces an immune response against seasonal influenza viruses.
This vaccine induces an immune response against seasonal influenza viruses. Used for Prevention of seasonal influenza disease.
At a glance
| Generic name | Seasonal influenza virus vaccine |
|---|---|
| Sponsor | AstraZeneca |
| Drug class | Influenza vaccine |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
By introducing antigens from seasonal influenza viruses, the vaccine stimulates the body's immune system to produce antibodies and immune cells that can recognize and fight the viruses. This provides protection against seasonal influenza infections.
Approved indications
- Prevention of seasonal influenza disease
Common side effects
- Pain, redness, or swelling at the injection site
- Fatigue
- Headache
Key clinical trials
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above (PHASE2)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants (PHASE3)
- Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
- A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (PHASE1)
- H1ssF Flu Vaccine Clinical Trial (PHASE1)
- Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine (PHASE1, PHASE2)
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Seasonal influenza virus vaccine CI brief — competitive landscape report
- Seasonal influenza virus vaccine updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Seasonal influenza virus vaccine
What is Seasonal influenza virus vaccine?
How does Seasonal influenza virus vaccine work?
What is Seasonal influenza virus vaccine used for?
Who makes Seasonal influenza virus vaccine?
What drug class is Seasonal influenza virus vaccine in?
What development phase is Seasonal influenza virus vaccine in?
What are the side effects of Seasonal influenza virus vaccine?
Related
- Drug class: All Influenza vaccine drugs
- Manufacturer: AstraZeneca — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of seasonal influenza disease
- Compare: Seasonal influenza virus vaccine vs similar drugs
- Pricing: Seasonal influenza virus vaccine cost, discount & access